Abiopharma

🔍 DELUCCIA ROBERT J (Director)

Company: Acurx Pharmaceuticals, Inc. (ACXP)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Acquired 37,100 shares of Stock Option at $2.36 per share (Derivative)
  Date: 2026-04-20 | Code: A | Expires: 2036-04-20 | equity_swap_involved: 0 | shares_owned_after: 37,100.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On April 20, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 37,100 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date.